Clinical & Molecular Cytopathology

Molecular Cytopathology is an emerging discipline within Cytopathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Cervical cancer is the third most common type of cancer among women worldwide. The infection and persistence of human papillomavirus (HPV) is the essential condition for this type of disease. However, only HPV infection is not enough for cervical pathogenesis are necessary cofactors and activation of intracellular and extracellular mechanisms to start.

In the conventional Pap smear, the physician collecting the cells smears them on a microscope slide and applies a fixative. In general, the slide is sent to a laboratory for evaluation. The studies include Liquid-based monolayer cytology and Human papillomavirus testing.

The overall cytology market is segmented into North America, Asia Pacific, Europe, Latin America and MEA. As of 2014, North America attributed the largest share in the market in terms of revenue owing to the increasing incidences of cancer in this region. As stated by American Cancer Society, U.S. is expected to hold one third of the total cancer cases worldwide. Europe is accounted for the second largest region in terms of growth of histology and cytology market. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to continuous technological advancements and rapidly increasing awareness regarding prevention procedures of cell based chronic diseases in this region. High unmet needs of the population residing in this region, is expected to further boost the growth of this region.

Molecular cytopathology (MCP) can be defined as molecular studies applied on all types of cytological specimens, namely gynaecology cytology, exfoliative non- gynaecology cytology and fine needle aspirates.

  • Clinical Correlation with Cytological Diagnosis
  • Clinical pathology and chemotherapy
  • Clinical impact in cytopathology
  • Cytopathology of molecular disease mechanisms

Related Conference of Clinical & Molecular Cytopathology

June 25-26, 2018

2nd International Conference on Microbial Pathogenesis and Infectious Diseases

Vancouver, Canada
(10 Plenary Forums, 2 Days, 1 Event)
June 20-21, 2018

15th European Pathology Congress

| Paris, France
June 25-26, 2018

15th CME Congress on Pathology and Cancer Research

Vancouver, Canada
August 29-30, 2018

4th International Conference on Cytopathology & Histopathology

Boston | Massachusetts | USA
Sep 17-18, 2018

16th Asia Pacific Pathology Congress

Tokyo, Japan

Clinical & Molecular Cytopathology Conference Speakers